Delivery Order SPE2DB22D2007-SPE2DB25FJ4SM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,142.47 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (quantity: 100s) on September 8, 2025, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 30 mg, with a ceiling value of $1,393.14. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 28, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,670.98. This firm fixed-price delivery order, which is due for completion by September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 30 mg, valued at $1,419.93. This competitive, non-set-aside contract was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizing firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall XR 15 mg capsules (100-count units) with a ceiling value of $5.38K. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100 units) with a ceiling value of $1,759.80. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract calls for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract value of $1,765.86. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,648.34. This competitively awarded, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (100-count units) valued at $1,453.18, with an ultimate completion date of September 4, 2025. This competitive award utilizes firm fixed-price pricing with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $5,384.37 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis and will be performed at the vendor's corporate office location...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4SMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 30 mg, with a ceiling value of $1,014.95. This firm fixed-price delivery order, awarded on September 8, 2025, represents a non-competitive set-aside contract and is scheduled for ultimate completion by September 9, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, through December 2026. As a prime IDC vehicle, this comprehensive contract enables AmerisourceBergen to supply pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and other government healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor for the Defense Logistics Agency's medical supply chain, delivering a wide range of brand-name and generic medications across multiple therapeutic domains to federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |